SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer
Journal of Biochemical and Molecular Toxicology · 2026
DOI: 10.1002/jbt.71080 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Peng Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, 411 Hospital of Shanghai University, Shanghai, China. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Drug Resistance, Neoplasm, Ferroptosis, Prostatic Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Project of Hongkou District Health Commission.
Abstract (Originalsprache)
Prostate cancer (PCa) remains a leading cause of cancer‐related mortality in aging male, with resistance to enzalutamide (Enza) representing a major therapeutic challenge. This study identifies SLC3A1 as a key driver of Enza resistance. Through integrative bioinformatics analysis of GEO datasets, we found SLC3A1 significantly upregulated in Enza‐resistant PCa models. WGCNA and single‐cell RNA sequencing confirmed its association with adverse prognosis and activation of key survival pathways. Functional experiments demonstrated that SLC3A1 knockdown reduced AKT phosphorylation, and inhibited colony formation in LNCaP cells. Conversely, SLC3A1 overexpression activated PI3K‐AKT signaling, suppressed ferroptosis and conferred Enza resistance in vitro and in vivo. These results reveal SLC3A1 is a promising therapeutic target for advanced prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, 411 Hospital of Shanghai University, Shanghai, China.
ORCID-Profile: Yuhang Qian
Förderung
- Medical Research Project of Hongkou District Health Commission
Zitieren
APA
Liu, P., Zhang, H., Qian, Y., Zhang, J., Deng, X., & Sun, B. (2026). SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.71080
Vancouver
Liu P, Zhang H, Qian Y, Zhang J, Deng X, Sun B. SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.71080
BibTeX
@article{Liu2026,
author = {Liu, Peng and Zhang, Haocheng and Qian, Yuhang and Zhang, Jiong and Deng, Xiaojun and Sun, Bin},
title = {SLC3A1 Mitigates Ferroptosis and Promotes Enzalutamide Resistance in Prostate Cancer},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
doi = {10.1002/jbt.71080}
}
EUVIMED